Samuel Agresta's Net Worth

$1.41 Million

Estimate Recalculated Apr 17, 2024 03:03PM EST

Who is Samuel Agresta?

Samuel Agresta has an estimated net worth of $1.41 Million. This is based on reported shares across multiple companies, which include Foghorn Therapeutics Inc., and INFINITY PHARMACEUTICALS, INC..

SEC CIK

Samuel Agresta's CIK is 0001748961

Past Insider Trading and Trends

2020 was Samuel Agresta's most active year for acquiring shares with 2 total transactions. Samuel Agresta's most active month to acquire stocks was the month of December. 2023 was Samuel Agresta's most active year for disposing of shares, totalling 2 transactions. Samuel Agresta's most active month to dispose stocks was the month of July. 2023 saw Samuel Agresta paying a total of $1,158,024.84 for 371,297 shares, this is the most they've acquired in one year. In 2023 Samuel Agresta cashed out on 622,594 shares for a total of $2,568,200.25, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Foghorn Therapeutics Inc. (FHTX) Snapshot price: $3.09

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
—
0
$5.99
-$1,410,175.41
0
Aug 16
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Jan 28
Form 3
—
0
—
—
0
No matching records found

INFINITY PHARMACEUTICALS, INC. (INFIQ) Snapshot price: $0.0002

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Oct 16
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Aug 6
Form 3
—
0
—
—
0
No matching records found